Ignite Creation Date:
2025-12-24 @ 8:01 PM
Ignite Modification Date:
2026-01-02 @ 1:28 AM
Study NCT ID:
NCT01151904
Status:
TERMINATED
Last Update Posted:
2013-02-06
First Post:
2010-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients
Sponsor:
Allergan
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MA-COM004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None